These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2918948

  • 21. Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
    Abrahamson DR, Hein A, Caulfield JP.
    Lab Invest; 1983 Jul; 49(1):38-47. PubMed ID: 6865329
    [Abstract] [Full Text] [Related]

  • 22. Synergy of monocytes and lymphocytes from idiopathic minimal lesion nephrotic patients in relapse in the production of the supernatant factor that increases rat glomerular basement membrane sulfate uptake.
    Garin EH, Boggs KP.
    Int J Pediatr Nephrol; 1987 Jul; 8(4):187-92. PubMed ID: 3449467
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.
    Komatsuda A, Wakui H, Iwamoto K, Harada M, Okumoto Y, Sawada K.
    Am J Nephrol; 2008 Jul; 28(4):539-47. PubMed ID: 18219197
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ, Geelen JM, Bakker M, Lensen JF, Rops AL, Kramer AB, Navis G, van den Hoven MJ, van der Vlag J, Berden JH, Wetzels JF, van den Heuvel LP, Monnens LA, van Kuppevelt TH.
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1998 Oct; 78(4):403-9. PubMed ID: 9578066
    [Abstract] [Full Text] [Related]

  • 29. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.
    Lin CY, Chien JW.
    Acta Paediatr Taiwan; 2004 Oct; 45(2):77-80. PubMed ID: 15335115
    [Abstract] [Full Text] [Related]

  • 30. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y, Yoshikawa N, Nakamura H.
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of supernatants from nephrotic peripheral blood mononuclear cells on 35sulfate incorporation in rat glomerular basement membrane.
    Garin EH, Boggs KP.
    Pediatr Res; 1985 Aug; 19(8):836-40. PubMed ID: 4034285
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
    Tanaka M, Furuhashi M, Moniwa N, Maeda T, Takizawa H, Matsumoto M, Sakai A, Higashiura Y, Gocho Y, Koyama M, Ogawa Y, Miura T.
    BMC Nephrol; 2020 Nov 03; 21(1):459. PubMed ID: 33143633
    [Abstract] [Full Text] [Related]

  • 35. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Ohi H, Kanmatsuse K.
    Nephron; 1999 Nov 03; 82(1):32-8. PubMed ID: 10224482
    [Abstract] [Full Text] [Related]

  • 36. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
    Koike K, Tsuboi N, Utsunomiya Y, Kawamura T, Hosoya T.
    Am J Nephrol; 2011 Nov 03; 34(6):542-8. PubMed ID: 22123493
    [Abstract] [Full Text] [Related]

  • 37. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
    van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S.
    Kidney Int; 2004 Nov 03; 66(5):1901-6. PubMed ID: 15496161
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma.
    Nakao K, Sugiyama H, Makino E, Matsuura H, Ohmoto A, Sugimoto T, Ichikawa H, Wada J, Yamasaki Y, Makino H.
    Nephron; 2002 Apr 03; 90(4):498-500. PubMed ID: 11961411
    [Abstract] [Full Text] [Related]

  • 40. [Changes in rat glomerular polyanion and ultrastructures induced by supernatants of cultured mononuclear cells from patients with steroid-response nephrotic syndrome].
    Wang Z, Liu Z.
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar 03; 26(1):29-32. PubMed ID: 7657333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.